Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ Capital MarketTotal Valuation
Telomir Pharmaceuticals, Inc. Common Stock carries a market capitalization of 79.78M, placing it among publicly traded companies globally.
| Market Cap | 79.78M |
| Enterprise Value | N/A |
Share Statistics
Telomir Pharmaceuticals, Inc. Common Stock currently has 34.38M shares outstanding.
| Shares Outstanding | 34.38M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 9.01 |
| P/TBV Ratio | 9.01 |
| P/FCF Ratio | -9.12 |
| P/OCF Ratio | -9.12 |
Financial Position
Telomir Pharmaceuticals, Inc. Common Stock maintains a current ratio of 7.00, meaning it holds 7.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 7.00 |
| Quick Ratio | 6.72 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -7,768.74 |
Financial Efficiency
| Return on Equity (ROE) | -2,196.29 |
| Return on Assets (ROA) | -293.73 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Telomir Pharmaceuticals, Inc. Common Stock's stock has declined approximately -6.45161% over the past 52 weeks. The 50-day moving average sits at 1.17, while the 200-day moving average is 1.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.45161% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.27 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -9.39M, while operating income came in at -9.39M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -9.39M |
| Pretax Income | -9.22M |
| Net Income | -9.22M |
| EBITDA | -9.39M |
| EBIT | -9.39M |
| Earnings Per Share (EPS) | -0.29 |
Balance Sheet
Total book value stands at 4.96M, with working capital of 4.96M providing operational flexibility.
| Cash & Cash Equivalents | 5.56M |
| Total Debt | N/A |
| Net Debt | -5.56M |
| Equity (Book Value) | 4.96M |
| Book Value Per Share | 0.14 |
| Working Capital | 4.96M |
Cash Flow
Telomir Pharmaceuticals, Inc. Common Stock produced -4.60M in operating cash flow over the past twelve months.
| Operating Cash Flow | -4.60M |
| Capital Expenditures | N/A |
| Free Cash Flow | -4.60M |
| FCF Per Share | -0.14 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -21.83 |
| FCF Yield | -10.96 |
Scores
Telomir Pharmaceuticals, Inc. Common Stock posts an Altman Z-Score of 17.93, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 17.93 |